Explore surgeries / Hysterectomy Explained
New research, guidelines and FDA decisions, each with a note on what it might change in a conversation with your surgeon, how certain it is, and links to the original sources.
How we choose news. Nothing here is sponsored. Mentioning a product isn't an endorsement, and an FDA clearance means a device was found substantially equivalent to existing ones, not proven better. Updated November 2026.
A JAMA Surgery trial follow-up found mesh-augmented hysteropexy, which keeps the uterus, was a durable, low-risk alternative to vaginal hysterectomy for prolapse. The specific mesh kit studied is no longer sold in the US.
What this could change in a conversation with your surgeon: For prolapse, hysterectomy isn't the only surgical option. Ask whether a uterus-sparing repair is possible for you.
Sources: 2 Minute Medicine
The FDA granted marketing authorization for the Claria System, which cuts and removes tissue considered benign inside a containment system during laparoscopic hysterectomy, through the vagina. The FDA says it's intended only for limited, appropriately selected patients.
What this could change in a conversation with your surgeon: If your uterus will be removed in pieces, ask how the tissue will be contained and whether you've been checked for cancer risk first.
Sources: FDA
A large US registry study of benign hysterectomies from 2012 to 2022 found low complication rates with both vaginal and laparoscopic hysterectomy. Vaginal surgery was shorter but more often meant an overnight stay.
What this could change in a conversation with your surgeon: Both are good options in experienced hands. Ask which your surgeon does most and why they recommend it for you.
Sources: MedBeats (AJOG summary)
See news across every procedure on the Informed Surgery news page.